Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1996
10/16/1996EP0648254B1 Luminescent article with high phosphor to binder ratio and manufacture thereof
10/16/1996EP0614886B1 Compound capable of intracerebral residence and use thereof
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0597007B1 W/o microemulsions
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0524989B1 Controlled release drug formulation
10/16/1996EP0414755B1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
10/16/1996CN1133604A Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
10/16/1996CN1133603A Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
10/16/1996CN1133561A Stabilized prostaglandin E 1
10/16/1996CN1133560A A stable pharmaceutical composition of terfenadine and isuprofen
10/16/1996CN1133558A Gelatin capsule fill able to foam
10/16/1996CN1133172A Powdered preparation for treating wounds and lesions
10/16/1996CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/15/1996US5565613 2-arylpropionic acid preparations and process for their production
10/15/1996US5565552 Method of expanded porphyrin-oligonucleotide conjugate synthesis
10/15/1996US5565548 Peptide having sequence of protective antibody-eliciting epitope and having mercapto groups linked to carrier comprising lipid vesicle containing amino moiety activated by polyaldehyde and cysteine
10/15/1996US5565519 Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
10/15/1996US5565491 Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
10/15/1996US5565487 Method of treating wrinkles using galactonic acid or galactonolactone
10/15/1996US5565471 Method for inhibiting thrombosis
10/15/1996US5565443 Contraceptics
10/15/1996US5565442 Dissolving in solvent with antioxidant and polyoxyalkyl stabilizer; compositing with carrier or excipient to impart solid characteristics; desolventizing; useful in conditions of vitamin d deficiency
10/15/1996US5565427 Stabilized factor VIII preparations
10/15/1996US5565423 Cyclopeptides and their use as absorption promoters when applied to the mucosa
10/15/1996US5565335 Adhesion variants
10/15/1996US5565215 Biodegradable injectable particles for imaging
10/15/1996US5565213 Containing taurine and benzalkonium chloride in external aqueous phase and in liposome
10/15/1996US5565188 Therapeutiac or diagnostic agents having polyoxyalkylene glycol triblock polymers adsorbed on particle surfaces
10/15/1996US5564458 Timing valve for the discontinuous metering of a volume flow
10/15/1996CA2042972C Treatment of ocular hypertension with a synergistic combination for ocular administration
10/15/1996CA2041074C Biocompatible viscoelastic gel slurries, their preparation and use
10/11/1996CA2148851A1 Atp-diphosphohydrolases and process of purification thereof
10/10/1996WO1996031551A1 Microgels
10/10/1996WO1996031539A1 Antibodies and their use in cancer therapy and diagnosis
10/10/1996WO1996031533A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996WO1996031239A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
10/10/1996WO1996031236A1 Chlamydia vaccines
10/10/1996WO1996031231A1 Controlled release biodegradable nanoparticles containing insulin
10/10/1996WO1996031220A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996WO1996031213A1 Pharmaceutical composition containing proton pump inhibitors
10/10/1996WO1996031207A1 Podofilox gel formulation
10/10/1996WO1996031205A1 Compositions and process for treating uremic pruritus
10/10/1996WO1996031203A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/10/1996WO1996031198A1 Controlled release insufflation carrier for medicaments
10/10/1996WO1996031197A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996WO1996031196A1 Novel compositions of lipids and stabilizing materials
10/10/1996WO1996026890A3 Method of producing hydrophilic or partially hydrophilic inorganic aerogels
10/10/1996WO1996026718A3 Controlled release tablet
10/10/1996WO1996017580A3 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents
10/10/1996CA2217305A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996CA2216934A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996CA2216599A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996CA2216363A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/09/1996EP0736545A2 Dextrin ester of fatty acids and use thereof
10/09/1996EP0736544A1 Oral care compositions
10/09/1996EP0736522A1 Ceramide compounds, process for their preparation and their use in cosmetics or dermatology
10/09/1996EP0736303A2 Interferon solution
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736045A1 Use of mono-3,6-anhydro-cyclodextrins for solubilising a hydrophobic compound and monitoring the purity of an enantiomer, and method for preparing said cyclodextrins
10/09/1996EP0736044A1 Cyclodextrin derivatives for solubilising hydrophobic chemical compounds such as drugs, and methods for preparing same
10/09/1996EP0736041A1 Transparent liquid for encapsulated drug delivery
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735898A1 Vaccines
10/09/1996EP0735896A1 Parathyroid hormone formulation
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735880A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
10/09/1996EP0735879A1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent.
10/09/1996EP0735876A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996EP0735862A1 Method for dry blend compression of medicaments
10/09/1996EP0735861A1 Tissue moisturizing and antimicrobial compositions
10/09/1996EP0648116B1 Composition for controlled release of an active substance and method for the preparation of such a composition
10/09/1996EP0637236B1 Pharmaceutical preparation and process for its manufacture
10/09/1996EP0630287B1 Microcapsules with primary alcohol functions containing polysaccharide walls and compositions containing them
10/09/1996EP0517740B1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1133012A Pharmaceutical formulations of nerve growth factor
10/09/1996CN1133006A Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple
10/09/1996CN1133005A Stabilized tablet formulation
10/09/1996CN1133004A Process for conditioning substances
10/09/1996CN1132646A Oyster-spirulina capsule and its prepn process
10/08/1996US5563250 For diagnosis, therapy
10/08/1996US5563153 Gel consists of tetracaine hydrochloride, epinephrine hydrochloride, coacaine hydrochloride and absorbable gelatin sterile powder
10/08/1996US5563134 Pharmaceutical compositions comprising clozapine and a radical scavenger
10/08/1996US5563132 Two-step cancer treatment method
10/08/1996US5563122 Stabilized parathyroid hormone composition
10/08/1996US5563056 Forming a matrix having first chemical species covalently immobilized and includes free molecules of second chemical species, gradually releasing the second species molecule from matrix
10/08/1996US5562924 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same
10/08/1996US5562923 Micronized pharmaceutically inhalable substances
10/08/1996US5562917 Includes water soluble methyl cellulose-type gel, and water
10/08/1996US5562911 Cosmetics
10/08/1996US5562898 Opacifier for water-based compositions
10/07/1996CA2146481A1 Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization
10/03/1996WO1996030057A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
10/03/1996WO1996030049A2 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996WO1996030047A1 Immunotargeting of plasminogen activators to the pulmonary endothelium
10/03/1996WO1996030041A1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution
10/03/1996WO1996030036A1 Compounds and compositions for delivering active agents
1 ... 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 ... 1712